Call for Abstract
Scientific Program
2nd International Conference and Exhibition on Cell & Gene Therapy, will be organized around the theme “Innovative Strategies in Cell & Gene Therapies”
Cell Therapy-2013 is comprised of 10 tracks and 71 sessions designed to offer comprehensive sessions that address current issues in Cell Therapy-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Molecular therapy
- Track 1-2Ocular therapy
- Track 1-3Neuro therapy for neurological diseases
- Track 1-4Cardiac cell therapy
- Track 1-5Cell therapies for renal failure
- Track 1-6RNA therapeutics
- Track 1-7Virotherapy
- Track 2-1Molecular basis of pluripotency
- Track 2-2Bone marrow stem cells as therapy
- Track 2-3Current views of the embryonic & neural stem cells
- Track 2-4Stem cell therapy for genetic disorders
- Track 2-5Targeting stem cells for therapeutic benefits
- Track 2-6Transplantation technologies in stem cell therapy
- Track 3-1Cell replacement therapy
- Track 3-2Potential uses of defined cell populations
- Track 3-3Reprogramming cell fate
- Track 3-4Role of molecular markers in therapies
- Track 3-5Target tissues and routes of delivery
- Track 3-6Causes of regenerative failure
- Track 4-1Tumour suppressor genes
- Track 4-2Biomarkers involved in gene therapy
- Track 4-3Genetic screening & diagnostics
- Track 4-4Cloning & expression systems
- Track 4-5Mobile genetic elements
- Track 4-6Vectors for gene therapy
- Track 4-7Cellular & organismal genetic engineering
- Track 4-8Gene transfer to induce cellular programming
- Track 4-9Therapies for genetic disorders/autoimmune disorders
- Track 4-10Molecular basis of epigenetics
- Track 5-1Cell based immunotherapy
- Track 5-2Cancers of immune cells
- Track 5-3New cell therapies for allergies
- Track 5-4Cell based immunosuppression in transplantation
- Track 5-5Tumour cells evade/defeat immune system
- Track 5-6Bio-Immune cellular therapy
- Track 6-1Stem cells & cancer treatments
- Track 6-2Characteristics of cancer cells
- Track 6-3Cell cycle and oncology
- Track 6-4Modern approaches in molecular cancer therapeutics
- Track 6-5Genomics & cancer drug resistance
- Track 6-6Cancer stem cells as a valuable target for diagnostic and therapy
- Track 6-7Genetically engineered cancer vaccines
- Track 6-8Therapeutic cancer vaccines
- Track 6-9Challenges & risks of cancer gene therapy
- Track 7-1Nano methods to target cancer cells
- Track 7-2Nano-microfluidics in cell therapy
- Track 7-3Nano materials and nano engineering
- Track 7-4Pros and cons of molecular manufacturing
- Track 7-5 Nanovaccines
- Track 8-1Biomedical engineering
- Track 8-2Developing new probes for tissue targeting
- Track 8-3Therapeutic bioengineering
- Track 8-4Cellular mechanobiology
- Track 8-5Tissue engineering from own stem cells
- Track 8-6Current understanding & challenges in bioprocessing
- Track 8-7Bioengineering for medical diagnostics and imaging
- Track 9-1Principles of gene therapy & clinical gene therapy
- Track 9-2Animal & human trials of engineered tissues
- Track 9-3Emerging clinical aspects of stem cell therapy
- Track 9-4Pharmacogenomics in cell therapy
- Track 9-5Clinical trial design and analysis
- Track 9-6 Clinical genetics
- Track 9-7Alternative lab models for therapeutic applications
- Track 10-1Commercialisation strategy
- Track 10-2Applications of cell therapy: From bench to bedside
- Track 10-3Cell therapy in future medicine
- Track 10-4Ethics involved in human stem cells
- Track 10-5Logistics in preparing lab models for cell therapy applications
- Track 10-6Manufacturing of cell therapy products and marketing guidelines
- Track 10-7Innovative therapeutic technologies
- Track 10-8FDA & EMA guidelines